Diginex launches Risk-to-Remedy solution

Diginex>>>, a provider of ESG, sustainability, and compliance solutions, announced the integration of its Risk-to-Remedy solution. This end-to-end supply chain due diligence offering is built on LUMEN for risk assessment and APPRISE for worker engagement, and incorporates expertise from the acquisition of The Remedy Project Limited>>>. The solution aims to bridge the gap between corporate declarations and demonstrable evidence of compliance with transparency regimes like the UK Modern Slavery Act, Australia's Modern Slavery Act, Canada's Fighting Against Forced Labour Act, and enforceable due diligence frameworks such as the CSDDD, German Supply Chain Due Diligence Act, and EU Forced Labour Regulation. The human rights and supply chain due diligence market is projected to grow significantly, driven by tighter regulation and increased investor scrutiny, making solutions like Risk-to-Remedy crucial for businesses to avoid product bans, regulatory fines, and reputational damage.